Neimeth International Pharmaceuticals Q2 2026 Board Meeting
Neimeth International Pharmaceuticals Plc has notified the Nigerian Exchange Limited that its Board of Directors will meet on 24th July 2026 to consider and approve the company's Unaudited Financial Statements for the period ended 30th June 2026. The filing also confirms that a closed period commenced on 1st July 2026 and will remain in effect until 24 hours after the meeting outcome and financial statements are released.
Neimeth International Pharmaceuticals Plc has filed a Board Meeting notice with the Nigerian Exchange Limited (NGX), dated 14th July 2026, disclosing that its Board of Directors is scheduled to convene on Friday, 24th July 2026. The purpose of the meeting is to consider and approve the company's Unaudited Financial Statements (UFS) for the second quarter ended 30th June 2026.
In accordance with NGX's Amended Closed Period Rules, Neimeth commenced a closed period on 1st July 2026. This closed period will remain active until 24 hours after the board meeting outcome and the Q2 2026 Unaudited Financial Statements have been released to the public.
As a result of the closed period, the company has notified its Directors and other insiders that they are prohibited from dealing in Neimeth's securities for the duration of the restriction. The filing was signed by Chinenye S. Adekanmbi, the Company Secretary. No financial figures were disclosed in this filing.
